Janus Henderson Investors US’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$131M Buy
1,339,007
+341,476
+34% +$32.6M 0.11% 237
2016
Q4
$91.7M Buy
997,531
+461,187
+86% +$39.7M 0.08% 317
2016
Q3
$45.4M Buy
536,344
+462,230
+624% +$38.8M 0.04% 436
2016
Q2
$6.03M Sell
74,114
-6,902
-9% -$526K 0.01% 746
2016
Q1
$5.79M Sell
81,016
-253,155
-76% -$17M 0.01% 755
2015
Q4
$23.8M Sell
334,171
-160,200
-32% -$10.8M 0.02% 574
2015
Q3
$30.4M Buy
494,371
+170,843
+53% +$11.9M 0.03% 516
2015
Q2
$23.5M Buy
323,528
+175,728
+119% +$13M 0.02% 578
2015
Q1
$11.4M Buy
147,800
+56,900
+63% +$4.07M 0.01% 692
2014
Q4
$6.1M Buy
90,900
+35,300
+63% +$2.23M 0.01% 775
2014
Q3
$3.37M Sell
55,600
-83,200
-60% -$5.13M ﹤0.01% 844
2014
Q2
$8.15M Sell
138,800
-386,600
-74% -$22.6M 0.01% 715
2014
Q1
$30.4M Buy
525,400
+285,600
+119% +$15.3M 0.03% 490
2013
Q4
$12.8M Buy
239,800
+198,500
+481% +$11.8M 0.01% 619
2013
Q3
$2.55M Buy
41,300
+30,800
+293% +$1.84M ﹤0.01% 835
2013
Q2
$637K Buy
+10,500
New +$626K ﹤0.01% 905

Other funds holding DGX

Janus Henderson Investors US's DGX Position: Q1 2017 in Review

Janus Henderson Investors US increased its Quest Diagnostics (DGX) stake by 34% in Q1 2017, buying an estimated $32.6M and bringing the position to 1,339,007 shares worth $131M. The position accounts for 0.11% of the portfolio, ranked #237.

Janus Henderson Investors US first reported a position in DGX in Q2 2013 and has held it in 16 quarters since. 614 funds tracked by Wall St. Rank hold DGX as of Q1 2017.

  • Janus Henderson Investors US held 1,339,007 shares of Quest Diagnostics worth $131M as of Q1 2017.
  • Janus Henderson Investors US bought 341,476 Quest Diagnostics shares in Q1 2017, an estimated $32.6M.
  • Quest Diagnostics made up 0.11% of Janus Henderson Investors US's portfolio in Q1 2017, its #237 holding.
  • Janus Henderson Investors US first reported a position in Quest Diagnostics in Q2 2013 and has held it in 16 quarters since.
  • 614 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.